Mirum Pharmaceuticals (MIRM) Net Margin Growth (1y) (2022 - 2026)

Mirum Pharmaceuticals (MIRM) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Mirum Pharmaceuticals 6.52 Bn 6.08 Bn 145.90 Mn -3,356.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,356.00
Mar 31, 2026 -48,106.00
Dec 31, 2025 2,008.00
Sep 30, 2025 1,793.00
Jun 30, 2025 2,705.00
Mar 31, 2025 2,337.00
Dec 31, 2024 2,734.00
Sep 30, 2024 3,367.00
Jun 30, 2024 16,581.00
Mar 31, 2024 5,884.00
Dec 31, 2023 7,928.00
Sep 30, 2023 14,070.00
Jun 30, 2023 -4,347.00
Mar 31, 2023 18,859.00
Dec 31, 2022 -195,592.00
Sep 30, 2022 75,203.00
Jun 30, 2022 24,506.00